We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GVA:NYSEGranite Construction Incorporated Analysis

Data as of 2026-04-07 - not real-time

$121.22

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Granite Construction trades at $121.22, roughly 13% above its DCF‑derived fair value of $107.47, implying an overvalued short‑term price but still leaves a calculated upside of about 26% versus current levels. Revenue is growing at 19.2% YoY and forward earnings are projected to rise sharply (trailing EPS $3.87 to forward $6.91), driving a forward PE of 17.5 versus a trailing PE of 31.3, which is modestly higher than the industry average of 29.7. The recent $114 million Caltrans contract award reinforces the pipeline and supports medium‑term earnings momentum, while the dividend yield of 0.43% with a low 13.5% payout ratio suggests sustainable shareholder returns.
Technical indicators are mixed: the 20‑day SMA sits just below price, the 50‑day SMA is above, RSI is neutral at 47, and MACD shows a bullish histogram despite a negative line, while volume trends downward. Combined with a beta of 0.78 and 30‑day volatility of 27.8%, the stock presents moderate risk, making it a cautious hold in the near term but a compelling buy for investors targeting the infrastructure growth story over the medium to long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral technical stance with price near short‑term support
  • Recent contract award adds near‑term earnings cushion
  • Decreasing volume and mixed MACD signals temper bullish bias

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and accelerating forward EPS
  • Forward PE of 17.5 indicates value relative to growth
  • Pipeline of public‑sector contracts supporting earnings stability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular U.S. infrastructure spending underpins demand
  • Solid cash position and low payout ratio sustain dividend
  • Balanced leverage with manageable debt profile

Key Metrics & Analysis

Financial Health

Revenue Growth19.20%
Profit Margin4.36%
P/E Ratio31.3
ROE19.15%
ROA4.95%
Debt/Equity122.60
P/B Ratio4.5
Op. Cash Flow$468.9M
Free Cash Flow$184.5M
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI46.9
Support$114.87
Resistance$127.18
MA 20$121.15
MA 50$125.72
MA 200$110.80
MACDBullish
VolumeDecreasing
Fear & Greed Index77.63

Valuation

Fair Value$107.47
Target Price$153.25
Upside/Downside26.42%
GradeOvervalued
TypeBlend
Dividend Yield0.43%

Risk Assessment

Beta0.78
Volatility27.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.